Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
441
-
Total 13F shares, excl. options
-
253M
-
Shares change
-
+9.67M
-
Total reported value, excl. options
-
$9.65B
-
Value change
-
+$367M
-
Put/Call ratio
-
0.48
-
Number of buys
-
201
-
Number of sells
-
-179
-
Price
-
$38.19
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2016
502 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q3 2016.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 253M shares
of 1.23B outstanding shares and own 20.6% of the company stock.
Largest 10 shareholders include DODGE & COX (59.3M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (31.3M shares), FRANKLIN RESOURCES INC (21.2M shares), Fisher Asset Management, LLC (12.4M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (12M shares), Invesco Ltd. (9.47M shares), Boston Partners (8.87M shares), BANK OF AMERICA CORP /DE/ (7.44M shares), FMR LLC (6.11M shares), and FEDERATED INVESTORS INC /PA/ (5.93M shares).
This table shows the top 441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.